The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study

Table 3 Critical bleeding and other bleeding

	Lansoprazole group (N = 109)	Esomeprazole group (N = 56)	P value
Critical bleeding-no. (%)	1 (0.9)	2 (3.6)	0.266
Other bleeding-no. (%)	10 (9.1)	7 (12.5)	0.590

ISSN: 2055-0294